en
Scientific article
English

Rhinophototherapy in chronic rhinosinusitis: a double blind randomized placebo-controlled trial

Published inRhinology, vol. 55, no. 2, p. 106-112
Publication date2017
Abstract

BACKGROUND: This study evaluated the efficacy of rhinophototherapy in patients with chronic rhinosinusitis (CRS) without nasal polyps. METHOD: In this randomized double-blind, placebo-controlled trial, CRS patients (n=50) received either mixed visible and ultraviolet (UVA and UVB) light source application (mUV/VIS) or visible light alone that served as placebo. Both groups were treated for 3 weeks. RESULTS: Results in the rhinophototherapy and placebo group were not significantly different and failed to reduce patient-reported outcomes measures (Rhinosinusits Disability Index, Visual Analogic Scale of symptom severity) and objective scores (rhinomanometry, olfactory thresholds, nasal Nitic Oxide concentrations), immediately and one month after treatment. CONCLUSIONS: The present data suggest that rhinophototherapy is not an efficient treatment for chronic rhinosinusitis without nasal polyps.

Keywords
  • Rhinophototherapy
  • Chronic rhinosinusitis
  • Trial
  • UV-A
  • UV-B
Citation (ISO format)
DULGUEROV, Nicolas et al. Rhinophototherapy in chronic rhinosinusitis: a double blind randomized placebo-controlled trial. In: Rhinology, 2017, vol. 55, n° 2, p. 106–112. doi: 10.4193/Rhin16.063
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0300-0729
427views
0downloads

Technical informations

Creation11/28/2017 10:57:00 PM
First validation11/28/2017 10:57:00 PM
Update time03/15/2023 7:38:25 AM
Status update03/15/2023 7:38:25 AM
Last indexation01/17/2024 1:51:12 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack